全文获取类型
收费全文 | 29947篇 |
免费 | 2162篇 |
国内免费 | 831篇 |
专业分类
耳鼻咽喉 | 146篇 |
儿科学 | 1175篇 |
妇产科学 | 548篇 |
基础医学 | 4232篇 |
口腔科学 | 543篇 |
临床医学 | 1895篇 |
内科学 | 5725篇 |
皮肤病学 | 766篇 |
神经病学 | 1666篇 |
特种医学 | 430篇 |
外国民族医学 | 5篇 |
外科学 | 2647篇 |
综合类 | 3129篇 |
现状与发展 | 1篇 |
预防医学 | 3751篇 |
眼科学 | 354篇 |
药学 | 3250篇 |
5篇 | |
中国医学 | 835篇 |
肿瘤学 | 1837篇 |
出版年
2023年 | 274篇 |
2022年 | 739篇 |
2021年 | 1117篇 |
2020年 | 807篇 |
2019年 | 1353篇 |
2018年 | 1198篇 |
2017年 | 1018篇 |
2016年 | 923篇 |
2015年 | 921篇 |
2014年 | 1473篇 |
2013年 | 1877篇 |
2012年 | 1299篇 |
2011年 | 1469篇 |
2010年 | 1197篇 |
2009年 | 1161篇 |
2008年 | 1178篇 |
2007年 | 1242篇 |
2006年 | 1140篇 |
2005年 | 995篇 |
2004年 | 982篇 |
2003年 | 884篇 |
2002年 | 754篇 |
2001年 | 691篇 |
2000年 | 508篇 |
1999年 | 454篇 |
1998年 | 408篇 |
1997年 | 389篇 |
1996年 | 341篇 |
1995年 | 325篇 |
1994年 | 260篇 |
1993年 | 185篇 |
1992年 | 187篇 |
1991年 | 152篇 |
1990年 | 166篇 |
1989年 | 121篇 |
1988年 | 132篇 |
1987年 | 105篇 |
1985年 | 405篇 |
1984年 | 549篇 |
1983年 | 395篇 |
1982年 | 448篇 |
1981年 | 410篇 |
1980年 | 343篇 |
1979年 | 310篇 |
1978年 | 288篇 |
1977年 | 229篇 |
1976年 | 300篇 |
1975年 | 228篇 |
1974年 | 206篇 |
1973年 | 206篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
目的:观察理筋通督手法治疗颈性眩晕的临床疗效。方法:将120例颈性眩晕患者随机分成3组,理筋通督组、传统手法组及安慰剂组。理筋通督组采用理筋通督手法;传统手法组采用传统手法;安慰剂组口服维生素C。结果:理筋通督手法可显著减缓患者基底动脉舒张期最低血流速度(P0.05)。理筋通督组有效率为93.67%,传统手法组有效率为67.5%,安慰剂组有效率为17.5%,3组比较差异有统计学意义(P0.05),理筋通督组明显优于其他两组。结论:理筋通督手法治疗颈性眩晕临床疗效显著。 相似文献
2.
3.
《Clinical gastroenterology and hepatology》2022,20(3):e380-e397
- Download : Download high-res image (232KB)
- Download : Download full-size image
4.
孤独症谱系障碍(ASD)是影响儿童健康的严重公共问题之一,以社交沟通障碍、兴趣或活动范围狭窄以及重复刻板行为为特征。近年来越来越多的研究显示,ASD患儿维生素D(VitD)水平明显低于同龄健康儿童,VitD缺乏可能与ASD的发病机制相关。本文就VitD与ASD的相关研究进行综述。 相似文献
5.
目的探讨维生素D(VitD)联合鱼油对糖尿病前期(PDM)患者糖脂代谢、胰岛β细胞功能的影响。 方法选取PDM患者132例,随机均分为联合组(VitD+鱼油)、VitD组(VitD)和对照组(不干预)。比较各组糖脂代谢、胰岛β细胞功能、炎症反应、血管内皮功能等指标。 结果与干预前比较,干预后联合组甘油三酯降低,白细胞介素-10增高(P<0.05),联合组和VitD组低密度脂蛋白胆固醇、肿瘤坏死因子-α、胰岛素抵抗指数、前列腺素E2、瘦素、抵抗素降低(P<0.05),空腹胰岛素、胰岛β细胞功能指数、脂联素增高(P<0.05),且联合组改善更为明显(P<0.05)。 结论维生素D联合鱼油治疗PDM患者可改善其脂代谢和胰岛功能相关指标,具有一定临床应用价值。 相似文献
6.
7.
I. R. Reid 《Journal of internal medicine》2015,277(6):690-706
There is an increasing number of effective therapies for fracture prevention in adults at risk of osteoporosis. However, shortcomings in the evidence underpinning our management of osteoporosis still exist. Evidence of antifracture efficacy in the groups of patients who most commonly use calcium and vitamin D supplements is lacking, the safety of calcium supplements is in doubt, and the safety and efficacy of high doses of vitamin D give cause for concern. Alendronate, risedronate, zoledronate and denosumab have been shown to prevent spine, nonspine and hip fractures; in addition, teriparatide and strontium ranelate prevent both spine and nonspine fractures, and raloxifene and ibandronate prevent spine fractures. However, most trials provide little information regarding long‐term efficacy or safety. A particular concern at present is the possibility that oral bisphosphonates might cause atypical femoral fractures. Observational data suggest that the incidence of this type of fracture increases steeply with duration of bisphosphonate use, resulting in concern that the benefit–risk balance may become negative in the long term, particularly in patients in whom the osteoporotic fracture risk is not high. Therefore, reappraisal of ongoing use of bisphosphonates after about 5 years is endorsed by expert consensus, and ‘drug holidays’ should be considered at this time. Further studies are needed to guide clinical practice in this area. 相似文献
9.
ObjectiveThe purpose of this paper is to review the efficacy and safety profile in children treated with topical 0.03% Tacrolimus ointment for vernal keratoconjunctivitis in Middle East and to propose a treatment posology. According to recent studies, a complex non-IgE dependent mechanism plays a relevant role in the pathogenesis of vernal keratoconjunctivitis. Numerous cells and mediators have been found in the serum, conjunctiva and tears of patients with Vernal keratoconjunctivitis.DesignThis case series included 10 patients from a single centre, pediatric department of a tertiary hospital with active symptomatic vernal keratoconjunctivitis. All the patients had proliferative lesions and corneal involvement despite conventional medications, including topical steroids. All other medications, systemic and topical: steroids, antihistamines and cyclosporine, were unsuccessful. Patients were treated with topical 0.03% Tacrolimus ointment twice daily for 8 weeks and then once a day for the next two month followed by thrice a week for two months. The changes in symptoms and signs after treatment were evaluated, also the development of possible complications was assessed.ResultsThe results showed a significant reduction in signs and symptoms after 4 weeks of the treatment. Clinical resolution of giant papillae and corneal lesions were seen within eight weeks and no additional drug was required during that period, except tear substitutes. Treatment was continued for period of two months and then slowly reduced.ConclusionThe use of 0.03% Tacrolimus ointment is safe and effective in children refractory to conventional treatment of vernal keratoconjunctivitis even in high temperature climate as Middle East. Due to the effectiveness of the treatment, the dosage used may be proposed for conventional use. 相似文献
10.
Hepatitis E virus (HEV) is the most common cause of acute liver failure (LF) and one of the most common factors causing acute injury in acute-on-chronic LF (ACLF). When HEV-related LF occurs, a series of changes take place in both the intrahepatic environment and extrahepatic microenvironment. The changed types and distribution of immune cells (infiltrating macrophages and increased lymphocytes) in liver tissue, as well the increased proinflammatory cytokines and chemokines in the blood, indicate that the occurrence and progression of HEV-related LF are closely related to immune imbalance. The clinical features and immune reaction in the body during HEV-related acute LF (ALF) and ACLF are complicated. This review highlights recent progress in elucidating the clinical manifestations of HEV-associated ALF and ACLF and discusses the corresponding systemic immune changes and possible regulatory mechanisms. 相似文献